BELLINI, Tiziana
 Distribuzione geografica
Continente #
NA - Nord America 14.480
AS - Asia 8.752
EU - Europa 5.146
SA - Sud America 1.310
AF - Africa 216
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 13
Totale 29.938
Nazione #
US - Stati Uniti d'America 14.187
SG - Singapore 3.255
CN - Cina 2.263
IT - Italia 1.088
BR - Brasile 1.018
VN - Vietnam 945
UA - Ucraina 804
DE - Germania 784
HK - Hong Kong 729
TR - Turchia 557
GB - Regno Unito 481
PL - Polonia 407
FI - Finlandia 369
FR - Francia 291
JP - Giappone 255
RU - Federazione Russa 238
SE - Svezia 227
IN - India 168
CA - Canada 134
MX - Messico 124
ID - Indonesia 110
AR - Argentina 105
BD - Bangladesh 93
NL - Olanda 85
ZA - Sudafrica 79
IQ - Iraq 60
BE - Belgio 53
ES - Italia 49
CO - Colombia 46
AT - Austria 43
CZ - Repubblica Ceca 41
EC - Ecuador 40
EE - Estonia 37
PK - Pakistan 34
VE - Venezuela 33
PH - Filippine 30
SA - Arabia Saudita 28
MY - Malesia 27
MA - Marocco 26
UZ - Uzbekistan 26
LT - Lituania 24
IR - Iran 22
CL - Cile 21
KR - Corea 20
AE - Emirati Arabi Uniti 18
PY - Paraguay 18
TN - Tunisia 18
ET - Etiopia 17
KE - Kenya 16
NP - Nepal 16
AU - Australia 15
EG - Egitto 15
BG - Bulgaria 14
DZ - Algeria 14
IE - Irlanda 14
AZ - Azerbaigian 12
RO - Romania 12
UY - Uruguay 12
PE - Perù 11
JO - Giordania 10
AL - Albania 9
EU - Europa 9
IL - Israele 9
JM - Giamaica 9
PT - Portogallo 9
SD - Sudan 9
KZ - Kazakistan 8
AO - Angola 7
BY - Bielorussia 7
CH - Svizzera 7
LB - Libano 7
OM - Oman 7
RS - Serbia 7
BO - Bolivia 6
DK - Danimarca 6
LV - Lettonia 6
PS - Palestinian Territory 6
TW - Taiwan 6
GE - Georgia 5
GR - Grecia 5
NZ - Nuova Zelanda 5
SI - Slovenia 5
SK - Slovacchia (Repubblica Slovacca) 5
TT - Trinidad e Tobago 5
A2 - ???statistics.table.value.countryCode.A2??? 4
HU - Ungheria 4
KW - Kuwait 4
MD - Moldavia 4
NI - Nicaragua 4
PA - Panama 4
DJ - Gibuti 3
HN - Honduras 3
HR - Croazia 3
KG - Kirghizistan 3
QA - Qatar 3
TH - Thailandia 3
ZW - Zimbabwe 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BH - Bahrain 2
Totale 29.903
Città #
Singapore 2.100
Ashburn 1.485
Woodbridge 1.185
San Jose 991
Fairfield 986
Chandler 927
Jacksonville 884
Beijing 714
Hong Kong 711
Houston 711
Ann Arbor 684
Santa Clara 679
Wilmington 409
Warsaw 391
Seattle 361
Dallas 318
Izmir 312
Cambridge 299
Ho Chi Minh City 290
Nanjing 255
Tokyo 246
Ferrara 241
Los Angeles 224
Hanoi 217
Princeton 207
Munich 185
Lauterbourg 170
Boardman 168
New York 136
Helsinki 127
Dearborn 123
Milan 122
Council Bluffs 104
Nanchang 95
São Paulo 90
Shanghai 88
Shenyang 87
Mexico City 78
San Diego 77
Addison 74
Tianjin 67
London 66
Turku 66
Changsha 65
Jakarta 65
Orem 59
Bologna 58
Chennai 54
Buffalo 52
Hebei 52
Bremen 50
Da Nang 50
Brussels 47
Hefei 46
Jiaxing 46
Montreal 45
Brooklyn 44
Chicago 43
Rome 43
Frankfurt am Main 42
Toronto 42
Moscow 41
Haiphong 38
Johannesburg 37
Jinan 36
Phoenix 34
Brno 33
Norwalk 33
Stockholm 33
Denver 32
Orange 32
Poplar 32
Ningbo 31
The Dalles 31
Vienna 31
Boston 30
San Francisco 30
Manchester 29
Guangzhou 28
Rio de Janeiro 28
Curitiba 27
Atlanta 26
Redwood City 25
Hải Dương 23
Kunming 22
Amsterdam 21
Ankara 21
Baghdad 21
Mountain View 21
Tashkent 21
Auburn Hills 20
Belo Horizonte 20
Leawood 20
Augusta 19
Brasília 19
Zhengzhou 19
Düsseldorf 18
San Mateo 18
Dong Ket 17
Charlotte 16
Totale 19.686
Nome #
Epstein-Barr Virus Specific Antibody Response in Multiple Sclerosis Patients during 21 Months of Natalizumab Treatment 412
Serum paraoxonase and arylesterase activities of paraoxonase-1 (PON-1), mild cognitive impairment, and 2-year conversion to dementia: A pilot study 293
Decreased Arylesterase activity of Paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases 279
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study. 273
Timing of serum active MMP-9 and MMP-2 levels in acute and subacute phases after spontaneous intracerebral hemorrhage 247
Evaluation of total, ceruloplasmin-associated and type II ferroxidase activities in serum and cerebrospinal fluid of multiple sclerosis patients 246
Antiglaucoma drops influence the production of advanced glycation end-products (AGEs) in the conjunctival sac fluid of glaucoma patients 245
Leishmania Infantum Cryptic Infection in Immunosuppressed Rheumatologic Patients and Healthy Controls from Northern Italy: Epidemiological Variables That Can Affect Infection Risk 241
TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis 238
“Bridging the Gap” Everything that Could Have Been Avoided If We Had Applied Gender Medicine, Pharmacogenetics and Personalized Medicine in the Gender-Omics and Sex-Omics Era 235
Chimica Medica e propedeutica Biochimica 224
Antiprotozoal activity of 6-aminonicotinamide against Leishmania infantum promastigotes 224
Evaluation of a possible role of oxidative stress in climacteric symptoms. 222
Mutual relationship between serum ferroxidase activity and hemoglobin levels in elderly individuals 222
A rapid method for purification of myelin basic protein 220
Transfusion of stored red blood cells in critically ill trauma patients: a retrospective study 215
Subclinical Leishmania infection in patients with rheumatic diseases under biological drugs 214
Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies 213
A proteomic approach to detect gelatinases levels and their inhibitors in patients with neurological diseases 210
Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients 205
Anomeric specificity and protein-substrate interactions support the 3D model for the hemagglutinin-neuraminidase from Sendai virus 203
Affinity distribution of anti-EBV IgG in the cerebrospinal fluid of patients with multiple sclerosis and in controls 203
Antiproliferative effects of novel synthetic nucleobase analogues on U937 Histiocytic lymphoma cell line 203
Activation of the sendai virus fusion protein by receptor binding 200
Activation of the Sendai virus fusion protein by receptor binding 200
A Comparison Between Different Anti-Retroviral Therapy Regimes on Soluble Inflammation Markers: a Pilot Study 199
Affinity labelling of the NADP+-binding site of glucose 6-phosphate dehydrogenase from Candida utilis 198
HUMAN ASYMPTOMATIC LEISHMANIA INFANTUM INFECTION. NEW INSIGHTS IN PATIENTS WITH CHRONIC RHEUMATIC DISEASES TREATED WITH BIOLOGICAL AGENTS AND LIVING IN RURAL AREAS OF NORTHERN ITALY 197
Matrix metalloproteinase 9 as a marker of disease activity in multiple sclerosis 193
Vaginal lactoferrin modulates PGE2, MMP-9, MMP-2, and TIMP-1 amniotic fluid concentrations 191
A machine-learning based bio-psycho-social model for the prediction of non-obstructive and obstructive coronary artery disease 189
Mutual communication of envelope glycoproteins of paramixoviruses 189
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study 186
Clinical and MRI activity are associated to elevated cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-9 in multiple sclerosis patients 186
Serum Gelatinases Levels in Multiple Sclerosis Patients during 21 Months of Natalizumab Therapy 186
Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis 186
Fast skeletal troponin i, but not the slow isoform, is increased in patients under statin therapy: A pilot study 185
Le beta-esosaminidasi liquorali in sogetti affetti da sclerosi multipla e in controlli sani 183
Analisi della proteina basica della mielina nel liquor 183
Long-term expression of highly differentiated functions by isolated porcine hepatocytes perfused in a radial-flow bioreactor 183
A Real-Time PCR to Detect Leishmania Infantum DNA in Immunocompetent Patients with Chronic Inflammatory Rheumatisms Living in Rural Areas of Northern Italy and Treated with Biologic Drugs. 183
Le Metalloproteasi come potenziali marcatori biologici nella Sclerosi Multipla 182
Increased age and male sex are independently associated with higher frequency of blood-cerebrospinal fluid barrier dysfunction using the albumin quotient 181
ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES Identification of a TIMP-1-resistant active MMP-9 in serum of Multiple Sclerosis patients 180
Development, optimization and validation of an absolute specific assay for active myeloperoxidase (MPO) and its application in a clinical context: Role of MPO specific activity in coronary artery disease 179
Effect of antiglaucoma drops on advanced glycation end-products (AGEs) levels in conjunctival sac fluid 178
Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding 178
Finding peculiar patterns of kinetoplastida enzymes to be exploited in drug design 178
Characterization of anti-coagulant properties of prenylated coumarin ferulenol. 177
Effect of pH on MMP-9 release by LPS-stimulated neutrophils 176
Sex difference impacts on the relationship between paraoxonase-1 (Pon1) and type 2 diabetes 176
Arylesterase activity of paraoxonase-1 in serum and cerebrospinal fluid of patients with alzheimer’s disease and vascular dementia 176
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 are elevated in in multiple sclerosis patients with disease activity 174
Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms 172
Multiplex Matrix Metalloproteinases Analysis in the Cerebrospinal Fluid Reveals Potential Specific Patterns in Multiple Sclerosis Patients 171
Testosterone-to-estradiol ratio and platelet thromboxane release in ischemic heart disease: the EVA project 171
Analysis of MMP-9 in CSF and sera of patients with neurological diseases 169
Myelin basic protein inhibits formyl-peptide induced chemotaxis in human neutrophils 168
Low Molecular Weight Heparin as inhibitor of gelatinases: possile anti-inflammatory role 168
Biochemical study in adult population with stroke in Ferrara, Fabry disease 166
Peptides derived from the heptad repeat region near the C-terminal of Sendai virus F protein bind the hemagglutinin-neuraminidase ectodomain 165
Lower airways inflammation in patients with ARDS measured using endotracheal aspirates: a pilot study. 165
Sex difference: an important issue to consider in epidemiological and clinical studies dealing with serum paraoxonase-1 165
Elevated CSF and serum levels and intrathecal synthesis of active MMP-2 in MS patients with no evidence of MRI disease activity 163
null 163
A catalytic tyrosine at the active site of sendai virus neuraminidase 161
Characterization of PAR-mediated signaling induced by activated coagulation factor X mutants 161
Conformational transitions during thermal inactivation of the neuraminidase from sendai virus 160
Purification of transglutaminase enzyme from Leishmania infantum promastigotes 160
A Calcium- and GTP-Dependent Transglutaminase in Leishmania infantum 158
Anomeric specificity of the neuraminidase from sendai virus 158
Substrate-induced intramolecular proton transfer in 6-phosphogluconate dehydrogenase from Candida utilis 156
Evidence for multiple pairs of vicinal thiols in some proteins 155
Non-enzymic protein phosphorylation. Phosphorylation of 6-phosphogluconate dehydrogenase by acyl phosphates 155
Mild proteolysis induces a ready-to-fuse state on Sendai virus envelope 154
Inhibition of Sendai virus hemagglutinin neuraminidase by the fusion protein 152
Hydroxyethyl Starch 130/0.4 Binds to Neutrophils Impairing Their Chemotaxis through a Mac-1 Dependent Interaction 152
Thermal stability of the hemagglutinin-neuraminidase from Sendai virus evidences two folding domains 150
The stabilization by a coenzyme analog of a conformational change induced by substrate in 6-phosphogluconate dehydrogenase 149
Decrease Paraoxonase-1 (PON-1) Activities in Neurodegenerative Diseases 149
Limited preotolysis of cHN, the soluble hemagglutinin neuraminidase from sendai virus 148
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis 148
6-fosfogluconato deidrogenasi da eritrociti umani: interazione con i coenzimi 147
Catalytic mechanism of 6-phosphogluconate dehydrogenase investigated by site-directed mutagenesis 147
Elevato riscontro di DNA circolante di Leishmania infantum in soggetti immunocompetenti affetti da malattie reumatologiche e trattati con farmaci biotecnologici. 147
Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study 145
Brain and serum cholesterol metabolism during perimenopausal transition: a risk factor for Alzheimer’s disease? 144
Gender differences in audio-vestibular disorders 144
The effect of inorganic phosphate on the stability of some enzymes 143
Matrix metalloproteinases (MMP): determination of different forms by different techniques may require different preanalytical strategies 143
Circulating Skeletal Troponin During Weaning From Mechanical Ventilation and Their Association to Diaphragmatic Function: A Pilot Study 142
Domain structure of the hemagglutinin-neuraminidase from sendai virus 142
Rilevanza delle forme attive delle gelatinasi nel monitoraggio dell'attività della Sclerosi multipla 141
INTRATHECAL PRODUCTION OF ACTIVE FORM OF MATRIX METALLOPROTEINASES-9 IN PATIENTS WITH MULTIPLE SCLEROSIS: PRELIMINARY RESULTS” 141
Pain in head and neck cancer patients: The role of gender 141
Myelin basic protein inhibits the calcium response to phytohaemagglutinin in human lymphocytes 140
Molecular defects of the glycine 41 variants of alanine glyoxylate aminotransferase associated with primary hyperoxaluria type I 140
Influence of different strategies of volume replacement on the activity of matrix metalloproteinases: an in vitro and in vivo study 138
Half-site reactivity in 6-phosphogluconate dehydrogenase from human erythrocytes 138
Purification of transglutaminase enzyme from L. infantum promastigotes 137
Totale 18.231
Categoria #
all - tutte 133.150
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 685
Totale 133.835


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021777 0 0 0 0 0 0 0 0 0 328 332 117
2021/20221.794 79 175 70 62 90 101 51 92 65 183 179 647
2022/20232.132 230 161 54 264 358 297 88 201 244 33 126 76
2023/2024952 98 121 62 25 95 89 25 66 30 23 28 290
2024/20254.210 119 78 375 164 528 329 142 246 650 565 564 450
2025/202611.324 1.119 552 1.168 1.547 1.634 781 1.458 660 1.147 1.258 0 0
Totale 30.273